393 related articles for article (PubMed ID: 21879445)
41. The role of histone deacetylases (HDACs) in human cancer.
Ropero S; Esteller M
Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
[TBL] [Abstract][Full Text] [Related]
42. Control of cardiac growth by histone acetylation/deacetylation.
Backs J; Olson EN
Circ Res; 2006 Jan; 98(1):15-24. PubMed ID: 16397154
[TBL] [Abstract][Full Text] [Related]
43. KATs in cancer: functions and therapies.
Farria A; Li W; Dent SY
Oncogene; 2015 Sep; 34(38):4901-13. PubMed ID: 25659580
[TBL] [Abstract][Full Text] [Related]
44. Histone deacetylases in memory and cognition.
Penney J; Tsai LH
Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
[TBL] [Abstract][Full Text] [Related]
45. Aberrant forms of histone acetyltransferases in human disease.
Van Beekum O; Kalkhoven E
Subcell Biochem; 2007; 41():233-62. PubMed ID: 17484131
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Histone Deacetylase Mechanisms in Cancer Development.
Hai R; He L; Shu G; Yin G
Front Oncol; 2021; 11():700947. PubMed ID: 34395273
[TBL] [Abstract][Full Text] [Related]
47. The emerging role of histone deacetylases (HDACs) in UPR regulation.
Kahali S; Sarcar B; Chinnaiyan P
Methods Enzymol; 2011; 490():159-74. PubMed ID: 21266250
[TBL] [Abstract][Full Text] [Related]
48. Histone deacetylases and mechanisms of regulation of gene expression.
Chen HP; Zhao YT; Zhao TC
Crit Rev Oncog; 2015; 20(1-2):35-47. PubMed ID: 25746103
[TBL] [Abstract][Full Text] [Related]
49. An Overview of HDAC Inhibitors and their Synthetic Routes.
Peng X; Liao G; Sun P; Yu Z; Chen J
Curr Top Med Chem; 2019; 19(12):1005-1040. PubMed ID: 30827245
[TBL] [Abstract][Full Text] [Related]
50. Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy-Chorney E; Denoncourt A; Sai Y; Downey M
Biochem Cell Biol; 2019 Feb; 97(1):30-45. PubMed ID: 29671337
[TBL] [Abstract][Full Text] [Related]
51. Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.
Balakin KV; Ivanenkov YA; Kiselyov AS; Tkachenko SE
Anticancer Agents Med Chem; 2007 Sep; 7(5):576-92. PubMed ID: 17896917
[TBL] [Abstract][Full Text] [Related]
52. The Acyl-CoA Specificity of Human Lysine Acetyltransferase KAT2A.
Anmangandla A; Ren Y; Fu Q; Zhang S; Lin H
Biochemistry; 2022 Sep; 61(17):1874-1882. PubMed ID: 35995428
[TBL] [Abstract][Full Text] [Related]
53. Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.
Roopa ; Priya B; Bhalla V; Kumar M; Kumar N
Chem Commun (Camb); 2021 Oct; 57(85):11153-11164. PubMed ID: 34613324
[TBL] [Abstract][Full Text] [Related]
54. Chemical and structural biology of protein lysine deacetylases.
Yoshida M; Kudo N; Kosono S; Ito A
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional Expression of Histone Acetyltransferases and Deacetylases During the Recovery of Acute Exercise in Mouse Hippocampus.
Qian P; Wang S; Zhang T; Wu J
J Mol Neurosci; 2024 Apr; 74(2):34. PubMed ID: 38565829
[TBL] [Abstract][Full Text] [Related]
56. Histone deacetylases: target enzymes for cancer therapy.
Mottet D; Castronovo V
Clin Exp Metastasis; 2008; 25(2):183-9. PubMed ID: 18058245
[TBL] [Abstract][Full Text] [Related]
57. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases.
Dekker FJ; van den Bosch T; Martin NI
Drug Discov Today; 2014 May; 19(5):654-60. PubMed ID: 24269836
[TBL] [Abstract][Full Text] [Related]
58. Expansion of the lysine acylation landscape.
Olsen CA
Angew Chem Int Ed Engl; 2012 Apr; 51(16):3755-6. PubMed ID: 22374739
[TBL] [Abstract][Full Text] [Related]
59. Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis.
Sun WJ; Zhou X; Zheng JH; Lu MD; Nie JY; Yang XJ; Zheng ZQ
Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):80-91. PubMed ID: 22194016
[TBL] [Abstract][Full Text] [Related]
60. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
Wang R; Sun H; Wang G; Ren H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
